Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$18,061,209
+$2,351,037 QoQ
Shares Held
71,774
-0.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#658
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. ABBV ranks #1 (39.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
71,774 | $18,061,209 | |
| 2 | JNJ |
Johnson & Johnson
|
22,283 | $5,659,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,088 | $3,866,308 | |
| 4 | NVS |
Novartis AG
|
23,712 | $3,716,144 | |
| 5 | PFE |
Pfizer Inc
|
153,401 | $3,693,896 | |
| 6 | NVO |
Novo Nordisk A S
|
63,650 | $3,051,381 | |
| 7 | LLY |
ELI LILLY & Co
|
1,772 | $2,125,390 | |
| 8 | SNY |
Sanofi
|
45,410 | $1,937,190 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,061,209 | 71,774 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $15,710,172 | 72,234 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $16,335,664 | 71,494 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $16,699,590 | 72,124 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,719,545 | 73,912 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $15,489,185 | 73,927 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $12,407,902 | 69,825 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $13,404,349 | 67,877 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $11,837,452 | 69,015 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $12,672,339 | 69,590 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,846,350 | 69,990 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,440,162 | 70,040 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,293,675 | 68,980 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,875,408 | 68,240 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $11,070,285 | 68,500 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $9,202,108 | 68,565 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $10,496,054 | 68,530 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $11,259,350 | 69,455 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,636,824 | 71,173 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,580,348 | 70,273 | Shares | Sole | 2021-12-02 | |
| 2021-06-30 | $7,631,247 | 67,749 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $6,990,903 | 64,599 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,356,566 | 59,324 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,812,982 | 54,949 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $5,105,261 | 51,999 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,970,718 | 52,116 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||